| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/02/2002 | EP1166643A1 Process for separating and recovering protein and isoflavones from a plant material |
| 01/02/2002 | EP1165826A1 Method for synthesis of polypeptides in cell-free systems |
| 01/02/2002 | EP1165782A1 Improved methods for recombinant peptide production |
| 01/02/2002 | EP1165773A1 Advanced antigen presentation platform |
| 01/02/2002 | EP1165615A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 01/02/2002 | EP1165612A2 A method for purifying human growth hormone |
| 01/02/2002 | EP1165599A1 Purification of biological preparations |
| 01/02/2002 | EP1005372B1 Anti-cd40l immunotoxins for the treatment of diseases |
| 01/02/2002 | EP0996627A4 Method for solution phase synthesis of oligonucleotides and peptides |
| 01/02/2002 | EP0941104A4 Peptide synthesis with sulfonyl protecting groups |
| 01/02/2002 | EP0722457B1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 01/02/2002 | CN1329103A Method for extracting protein, short peptide, nucleic acid, isoflavone, saponin and oligosaccharide by using high and low temperature soybean cake |
| 01/01/2002 | US6335461 Extracting with specified organic solvent from aqueous reaction solution or slurry, further purifying by crystallization, chromatography, extraction or absorption on activated charcoal |
| 01/01/2002 | US6335453 Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids |
| 01/01/2002 | US6335443 Chemical synthesis of exochelins |
| 01/01/2002 | US6335438 Method for the manufacture of amino group containing support matrices, support matrices prepared by the method, and use of the support matrices |
| 01/01/2002 | US6335430 Process of producing polyphenolic adhesive proteins and proteins produced in accordance with the process |
| 01/01/2002 | US6335176 Reagent is succinimidyl moiety linked to kinase substrate; can be linked to free primary or secondary amine in compound to be phosphorylated |
| 01/01/2002 | US6335017 Compositions and methods for treating viral infections |
| 01/01/2002 | CA2181477C Analogs of thymosin .alpha.1 |
| 01/01/2002 | CA2097192C Bombesin antagonists |
| 01/01/2002 | CA2081665C Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
| 01/01/2002 | CA2026376C Anticoagulant peptides |
| 01/01/2002 | CA1341330C Substituted acyl dertivatives of 1,2,3,4-tetrahydroisquinoline-3-carboxylic acids |
| 12/27/2001 | WO2001098473A2 Method for isolating and purifying a protein and resulting protein |
| 12/27/2001 | WO2001098354A2 Human receptors |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098328A2 Glycopeptide phosphonate derivatives |
| 12/27/2001 | WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |
| 12/27/2001 | WO2001046214A3 Compound comprising a nucleic acid moiety and an organo-silane moiety |
| 12/27/2001 | US20010056179 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity |
| 12/27/2001 | US20010055583 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 12/27/2001 | CA2713965A1 Glycopeptide phosphonate derivatives |
| 12/27/2001 | CA2414015A1 Human receptors |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/26/2001 | CN1328601A Methods and systems for predicting protein function |
| 12/25/2001 | US6333398 Protein purification |
| 12/25/2001 | US6333175 Yield when disulfide-bonded proteins are secreted |
| 12/25/2001 | US6333157 Disassociation of interacting molecules |
| 12/25/2001 | CA2018714C Hypothalamic polypeptides with adenylate cyclase stimulating activity |
| 12/20/2001 | WO2001097098A2 Computational molecular docking methods for assessing complementarity of combinatorial libraries to biotargets |
| 12/20/2001 | WO2001096869A1 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | WO2001096282A1 Method for producing amides or esters |
| 12/20/2001 | WO2001028511A3 Selective removal of contaminants from a surface using magnets |
| 12/20/2001 | WO2000065467A9 Methods for identifying pharmacophore containing molecules from a virtual library |
| 12/20/2001 | US20010053537 Electrophoresis separation and treatment of samples |
| 12/20/2001 | US20010053533 Detecting infectious protein in solution; prepare solution composed from body fluid or fluidized organ expose to chromatographic column, detect infectious protein |
| 12/20/2001 | US20010053366 Method of removing endotoxin from vaccines |
| 12/20/2001 | US20010052976 Scanning optical detection system |
| 12/20/2001 | US20010052462 Small separation apparatus |
| 12/20/2001 | DE10028402A1 New pyridinylamino-alkanoyl-glycyl-beta-alanine derivatives, are integrin inhibitors useful for treating, e.g. thrombosis, cardiac infarction, coronary heart disease, inflammation, tumors, osteoporosis or restenosis |
| 12/20/2001 | CA2411190A1 Molecular docking methods for assessing complementarity of combinatorial libraries to biotargets |
| 12/20/2001 | CA2410604A1 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/19/2001 | EP1164143A1 Process for preparing octreotide and derivatives thereof |
| 12/19/2001 | EP1163639A1 Protein modeling tools |
| 12/19/2001 | EP1163519A1 Protein isolation and analysis |
| 12/19/2001 | EP1163374A2 Arrays of organic compounds attached to surfaces |
| 12/19/2001 | EP1163268A1 Ion exchange chromatographic separation of glp-1 and related peptides |
| 12/19/2001 | EP1163264A1 Novel lhrh antagonists with improved solubility characteristics |
| 12/19/2001 | EP1163261A1 Ion exchange chromatography of proteins and peptides with an organic modifier in the elution step |
| 12/19/2001 | EP1163260A1 Process for partitioning of proteins |
| 12/19/2001 | EP1163211A1 Method for acylating peptides and novel acylating agents |
| 12/19/2001 | EP1163044A1 Negatively charged membrane |
| 12/19/2001 | EP0751779B1 Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 12/19/2001 | EP0727045B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 12/19/2001 | EP0721449B1 Inhibitors of beta-amyloid protein production |
| 12/19/2001 | EP0666866B1 Method of isolating biomolecules by ion exchange |
| 12/19/2001 | EP0528820B2 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase |
| 12/19/2001 | CN1327452A Fibroblast growth factor with hepatocyte proliferation activity |
| 12/19/2001 | CN1326939A Producing influenza killed vaccine by sepharose 4FF column chromatography technology |
| 12/19/2001 | CN1076204C Recombinant coccidiosis vaccines |
| 12/18/2001 | US6331522 Antibacterial and antifungal peptide |
| 12/18/2001 | US6331416 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
| 12/18/2001 | US6331274 Advanced active circuits and devices for molecular biological analysis and diagnostics |
| 12/18/2001 | US6331273 Remotely programmable matrices with memories |
| 12/18/2001 | CA2224052C Pertussis outer membrane protein |
| 12/18/2001 | CA2215531C Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
| 12/18/2001 | CA2201762C Method for purifying keratinocyte growth factors |
| 12/13/2001 | WO2001094945A2 Method for enhancing the solubility of proteins by alkylating reagents |
| 12/13/2001 | WO2001094587A2 Extracellular messengers |
| 12/13/2001 | WO2001094421A2 Method for electrophoretically separating membrane proteins |
| 12/13/2001 | WO2001094332A1 Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
| 12/13/2001 | WO2001094327A1 Catalyst comprising soluble polymer and polyamino acid |
| 12/13/2001 | WO2001072412A8 Method and device for investigating substance libraries |
| 12/13/2001 | WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 12/13/2001 | WO2000078791A3 FUNCTIONAL POLY-α-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION |
| 12/13/2001 | US20010051708 Purifying antibody; prepare antibody suspension, mix with water soluble liquid, recover clarified antibody, apply to chromatography column, elute antibody, concentrate antibody |
| 12/13/2001 | US20010051380 Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix |
| 12/13/2001 | US20010051336 Nucleotide-protein fusion; for use as a diagnostic tool in the decision of preferential particles |
| 12/13/2001 | DE10027705A1 Separation of membrane proteins, useful for proteosome analysis, by attaching membranes to carrier then performing electrophoretic migration |
| 12/13/2001 | CA2411684A1 Method for electrophoretically separating membrane proteins |
| 12/13/2001 | CA2409342A1 Extracellular messengers |
| 12/12/2001 | EP1162206A2 Peptide nucleic acids |
| 12/12/2001 | EP1161737A1 Method and apparatus for generating polycyclic fragments |
| 12/12/2001 | EP1161452A2 Covalently bridged insulin dimers |
| 12/12/2001 | EP1161450A1 Bone stimulating factor |